At EuroMedLab 2025, we were joined by Nicole Selenko-Gebauer, Group Vice President and Chief Innovation Officer at Danaher Diagnostics, who shared her insights at what the future holds. In the two videos below, Selenko-Gebauer details Dahaher’s upcoming diagnostic priorities, addressing pressing needs in neurodegenerative disease diagnosis, and innovation in infectious disease monitoring.
False
Explore More in Pathology
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False
Recommended
False
Related Content

A Helping Hand from AI in Prostate Cancer Diagnostics
February 8, 2022
3 min read
Using AI to enhance personalized healthcare for patients with prostate cancer

The Ultimate Vision for Rare Disease
February 28, 2022
1 min read
Genomics and computational pathology can take rare disease diagnostics to the next level

A Light in the Darkness
March 4, 2022
2 min read
Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

In-House Matters
April 7, 2022
3 min read
Molecular pathology is complex – and the benefits of keeping it local are extensive